MEGAN BRYANT: Open Payments
NPI 1750132171 · JACKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,672 in 145 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,277 · 2025 $2,672
Food & beverage: $2,554Education: $118
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $408 |
| Teva Pharmaceuticals USA, Inc. | 25 | $358 |
| E.R. Squibb & Sons, L.L.C. | 5 | $284 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $272 |
| Lundbeck LLC | 10 | $227 |
| Alkermes, Inc. | 10 | $205 |
| Vanda Pharmaceuticals Inc. | 11 | $205 |
| Axsome Therapeutics, Inc. | 9 | $181 |
| Otsuka America Pharmaceutical, Inc. | 10 | $171 |
| Janssen Pharmaceuticals, Inc | 2 | $150 |
Products named: VRAYLAR, COBENFY, CAPLYTA, REXULTI, ARISTADA, Auvelity, ABILIFY ASIMTUFII, SPRAVATO.
Industry payments across TN — which companies pay providers there.
